Hyperprolactinemia Completed Phase Trials for Aripiprazole (DB01238)

Also known as: Hyperprolactinemic disorder / Hyperprolactinaemia / Hyperprolactinemia (disorder)

IndicationStatusPhase
DBCOND0000952 (Hyperprolactinemia)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01338298Double-Blind Placebo Controlled Study of Adjunctive Aripiprazole for Symptomatic Hyperprolactinemia In Premenopausal Women With SchizophreniaTreatment